Skip navigation.

Welcome to SAfAIDS

SAfAIDS news

Mozambique Tackles its Twin Burden of Cervical Cancer and HIV

MAPUTO, 6 November 2014 (IPS) - The woman on bed 27 in Maputo Central Hospital’s oncology ward has no idea how lucky she is. In January, when abdominal pains racked her, a pharmacist suggested pain killers. For months, “the pain would go and return,” she told IPS.

Africa: Exciting New HIV Prevention Products in Pipeline

CAPE TOWN , 4 November 2014 (allAfrica) - Vaginal rings filled with antiretrovirals (ARVs), ARV injections and partially effective vaccines are some of the HIV prevention weapons under development.

Zimbabwe: ARVs price drops

HARARE - A partnership by the National AIDS Council (NAC), NatPharm and some pharmarcies in the private sector has resulted in the drop in prices of anti-retroviral drugs (ARVs) that will now be accessed for US$17 down from an average US$55 currently prevailing.


WHO interim guidance on the use of delamanid in the treatment of MDR-TB

BARCELONA, 30 October 2014 (allAfrica) - A new TB drug with a novel mechanism of action – delamanid - is now available for treatment of adults with multidrug-resistant tuberculosis (MDR-TB), a form of tuberculosis resistant to at least isoniazid and rifampicin, the main first-line drugs.

South Africa: Government to Host 21st International AIDS Conference

JOHANNESBURG, 28 October 2014 (allAfrica) - Durban will host the 21st International AIDS Conference from 17 to 22 July 2016 where scientists, world leaders, and people living with HIV will discuss successes and challenges in combating the epidemic.

Uganda's New Burden of HIV

KAMPALA (The Independent) - Government policies and spending key to achieving an HIV-free generation.  The debate about a prospective HIV-free generation given the advent of WHO Option B+ attracts attention. Further probing of the idea may expose it as a distant utopia. To have an HIV-free generation, our communities must come to a convergence on reducing new infections.


Syndicate content